Lexaria Bioscience (LEXX) Return on Capital Employed [ROCE] (2018 - 2026)
Lexaria Bioscience (LEXX) posted Return on Capital Employed [ROCE] of -146.79% for fiscal Q3 2026 (quarter ended May 31, 2026), up 36.37 percentage points from -183.16% a year earlier and up 9.53 percentage points from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Return on Capital Employed [ROCE] came in at -236.29%, down 118.31 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -72.04 percentage points (FY2020 to FY2025).
- In prior fiscal years, Lexaria Bioscience's Return on Capital Employed [ROCE] was -117.98% in FY2024 (+7.89 pp), -125.87% in FY2023 (-61.95 pp), -63.91% in FY2022 (+8.12 pp) and -72.04% in FY2021 (+92.22 pp).
- The fiscal Q3 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since fiscal Q2 2025.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -47.23 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was fiscal Q1 2022, with a gain of 122.33 percentage points; the weakest was fiscal Q4 2025, with a drop of 230.71 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior fiscal quarters was -156.33% (Q2 2026), -294.38% (Q1 2026) and -299.66% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | -146.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -146.79% |
| Feb 28, 2026 | -156.33% |
| Nov 30, 2025 | -294.38% |
| Aug 31, 2025 | -299.66% |
| May 31, 2025 | -183.16% |
| Feb 28, 2025 | -126.63% |
| Nov 30, 2024 | -80.87% |
| Aug 31, 2024 | -68.95% |
| May 31, 2024 | -58.09% |
| Feb 29, 2024 | -108.44% |
| Nov 30, 2023 | -185.02% |
| Aug 31, 2023 | -167.79% |
| May 31, 2023 | -154.54% |
| Feb 28, 2023 | -116.47% |
| Nov 30, 2022 | -93.60% |
| Aug 31, 2022 | -79.83% |
| May 31, 2022 | -71.24% |
| Feb 28, 2022 | -64.14% |
| Nov 30, 2021 | -56.87% |
| Aug 31, 2021 | -48.38% |
API Access
Lexaria Bioscience Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();